Opioids Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

Description

Persistence Market Research presents an in-depth analysis of the Opioids Market, offering insights into its intricate dynamics and future trajectory. From market trends to growth catalysts, impediments, and emerging patterns, this report furnishes invaluable statistics and projections spanning from 2024 to 2033.

Key Insights:

Opioids Market Size (2024): USD 45.75 Billion
Projected Market Value (2033): USD 61.1 Billion
Global Market Growth Rate (CAGR 2024 to 2033): 3.3%

Opioids Market - Report Scope:

The Opioids Market encompasses various applications across industries such as healthcare, pharmaceuticals, and pain management. Opioids are widely used as analgesics for treating moderate to severe pain, including pain associated with surgeries, cancer, and chronic conditions. This market caters to a wide range of end-users, including hospitals, clinics, and home care settings, offering critical pain management solutions. Market growth is driven by factors such as increasing incidence of chronic pain, advancements in drug formulations, and the rising demand for effective pain management therapies.

Market Growth Drivers:

The global Opioids Market is bolstered by several key growth drivers. The increasing incidence of chronic pain conditions, coupled with an aging population, drives the demand for effective pain management solutions. Moreover, advancements in drug formulations enhance the efficacy and safety of opioid medications, fostering their adoption in various medical settings. Additionally, the rising prevalence of surgical procedures and cancer treatments contributes to the growing demand for opioids as essential analgesics.

Market Restraints:

Despite its promising growth prospects, the Opioids Market faces challenges related to regulatory compliance, addiction concerns, and competition from alternative pain management therapies. Stringent regulatory requirements regarding opioid prescribing and usage impose compliance burdens on healthcare providers and manufacturers, impacting market expansion. Furthermore, the potential for addiction and misuse poses significant public health challenges, necessitating stringent controls and patient monitoring. Additionally, competition from non-opioid analgesics and alternative pain management approaches can affect market growth.

Market Opportunities:

The Opioids Market presents lucrative growth opportunities driven by technological innovation, industry collaborations, and market diversification. Emerging trends such as abuse-deterrent formulations, personalized medicine, and telemedicine inspire manufacturers to explore new formulations and delivery methods for opioids. Moreover, strategic partnerships, research collaborations, and mergers and acquisitions enable market players to expand their product portfolios, enhance their technical capabilities, and strengthen their market presence in key regions. Furthermore, growing investments in research and development, coupled with increasing government support for innovation and public health initiatives, create a conducive environment for market expansion and diversification.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the Opioids Market globally?
How are technological advancements and industry trends shaping the evolution of opioid formulations and delivery methods?
What are the key challenges and opportunities facing market participants in the opioids segment?
Which medical sectors and geographic regions offer the highest growth potential for opioid manufacturers?
What strategies are leading companies employing to differentiate their opioid offerings and capture market share in the competitive pharmaceutical landscape?

Competitive Intelligence and Business Strategy:

Leading players in the global Opioids Market, including pharmaceutical companies and healthcare providers, focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in research and development to develop advanced drug formulations, improve product safety, and explore new applications for opioids in pain management. Moreover, strategic collaborations with research institutions, academic partners, and healthcare associations enable market players to access new technologies, expand their knowledge base, and accelerate product development efforts. Furthermore, emphasis on regulatory compliance, quality assurance, and patient support enhances brand reputation and fosters long-term relationships with customers and stakeholders.

Key Companies Profiled:

Johnson & Johnson Services, Inc.
Purdue Pharma L.P.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mallinckrodt Pharmaceuticals
Endo International plc
AbbVie Inc.
Sun Pharmaceutical Industries Ltd.
Mylan N.V.
Boehringer Ingelheim International GmbH
Egalet Corporation
Orexo AB

Opioids Market Research Segmentation:

By Product:

Morphine
Codiene
Fentanyl
Meperidine
Methadone

By Application:

Analgesia
Cough Suppression
Diarrhea Suppression

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Store
Clinics
Others

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Product Code: PMRREP3066

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Adoption Rate/Usage Analysis - Key Statistics
4.2. Value Chain Analysis
4.3. Key Regulations - By Region
4.4. Product USP Analysis
4.5. Pipeline Assessment
4.6. PESTEL Analysis
4.7. Porter's Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Outlook
- 5.1.3. Global Analgesics Market Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Rising Prevalence of Chronic Diseases and Trauma Conditions
- 5.2.2. Less Availability of Opioids in African Nations
- 5.2.3. Increasing Product Approvals
- 5.2.4. Increasing Commercialization of Products
- 5.2.5. Mergers and Acquisitions
- 5.2.6. Regulatory Policies
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Product
- 6.1.2. By Application
- 6.1.3. By Distribution Channel
- 6.1.4. By Region
6.2. 2024 Market Scenario

7. Global Opioids Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Opioids Market Analysis 2019-2023 and Forecast 2024-2033, By Product

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis, by Product, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Product, 2024-2033
- 8.3.1. Morphine
- 8.3.2. Codiene
- 8.3.3. Fentanyl
- 8.3.4. Meperidine
- 8.3.5. Methadone
8.4. Market Attractiveness Analysis, by Product

9. Global Opioids Market Analysis 2019-2023 and Forecast 2024-2033, By Application

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Application, 2024-2033
- 9.3.1. Analgesia
- 9.3.2. Cough Suppression
- 9.3.3. Diarrhea Suppression
9.4. Market Attractiveness Analysis, by Application

10. Global Opioids Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Distribution Channel, 2024-2033
- 10.3.1. Hospital Pharmacies
- 10.3.2. Retail Pharmacies
- 10.3.3. Drug Store
- 10.3.4. Clinics
- 10.3.5. Others
10.4. Market Attractiveness Analysis, by Distribution Channel

11. Global Opioids Market Analysis 2019-2023 and Forecast 2024-2033, By Region

11.1. Introduction
11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
11.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, By Region, 2024-2033
- 11.3.1. North America
- 11.3.2. Latin America
- 11.3.3. Europe
- 11.3.4. East Asia
- 11.3.5. South Asia
- 11.3.6. Oceania
- 11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis, by Region

12. North America Opioids Market Analysis 2019-2023 and Forecast 2024-2033

12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 12.3.1. By Country
  - 12.3.1.1. U.S.
  - 12.3.1.2. Canada
- 12.3.2. By Product
- 12.3.3. By Application
- 12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Product
- 12.4.3. By Application
- 12.4.4. By Distribution Channel
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
- 12.8.1. U.S. Opioids Market Analysis
  - 12.8.1.1. Introduction
  - 12.8.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 12.8.1.2.1. By Product
    - 12.8.1.2.2. By Application
    - 12.8.1.2.3. By Distribution Channel
- 12.8.2. Canada Opioids Market Analysis
  - 12.8.2.1. Introduction
  - 12.8.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 12.8.2.2.1. By Product
    - 12.8.2.2.2. By Application
    - 12.8.2.2.3. By Distribution Channel

13. Latin America Opioids Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 13.3.1. By Country
  - 13.3.1.1. Mexico
  - 13.3.1.2. Brazil
  - 13.3.1.3. Argentina
  - 13.3.1.4. Rest of Latin America
- 13.3.2. By Product
- 13.3.3. By Application
- 13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product
- 13.4.3. By Application
- 13.4.4. By Distribution Channel
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
- 13.8.1. Mexico Opioids Market Analysis
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 13.8.1.2.1. By Product
    - 13.8.1.2.2. By Application
    - 13.8.1.2.3. By Distribution Channel
- 13.8.2. Brazil Opioids Market Analysis
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 13.8.2.2.1. By Product
    - 13.8.2.2.2. By Application
    - 13.8.2.2.3. By Distribution Channel
- 13.8.3. Argentina Opioids Market Analysis
  - 13.8.3.1. Introduction
  - 13.8.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 13.8.3.2.1. By Product
    - 13.8.3.2.2. By Application
    - 13.8.3.2.3. By Distribution Channel

14. Europe Opioids Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. Germany
  - 14.3.1.2. Italy
  - 14.3.1.3. France
  - 14.3.1.4. U.K.
  - 14.3.1.5. Spain
  - 14.3.1.6. BENELUX
  - 14.3.1.7. Russia
  - 14.3.1.8. Rest of Europe
- 14.3.2. By Product
- 14.3.3. By Application
- 14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By Application
- 14.4.4. By Distribution Channel
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
- 14.8.1. Germany Opioids Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.8.1.2.1. By Product
    - 14.8.1.2.2. By Application
    - 14.8.1.2.3. By Distribution Channel
- 14.8.2. Italy Opioids Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.8.2.2.1. By Product
    - 14.8.2.2.2. By Application
    - 14.8.2.2.3. By Distribution Channel
- 14.8.3. France Opioids Market Analysis
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.8.3.2.1. By Product
    - 14.8.3.2.2. By Application
    - 14.8.3.2.3. By Distribution Channel
- 14.8.4. U.K. Opioids Market Analysis
  - 14.8.4.1. Introduction
  - 14.8.4.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.8.4.2.1. By Product
    - 14.8.4.2.2. By Application
    - 14.8.4.2.3. By Distribution Channel
- 14.8.5. Spain Opioids Market Analysis
  - 14.8.5.1. Introduction
  - 14.8.5.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.8.5.2.1. By Product
    - 14.8.5.2.2. By Application
    - 14.8.5.2.3. By Distribution Channel
- 14.8.6. BENELUX Opioids Market Analysis
  - 14.8.6.1. Introduction
  - 14.8.6.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.8.6.2.1. By Product
    - 14.8.6.2.2. By Application
    - 14.8.6.2.3. By Distribution Channel
- 14.8.7. Russia Opioids Market Analysis
  - 14.8.7.1. Introduction
  - 14.8.7.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.8.7.2.1. By Product
    - 14.8.7.2.2. By Application
    - 14.8.7.2.3. By Distribution Channel

15. East Asia Opioids Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Distribution Channel (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. China
  - 15.3.1.2. Japan
  - 15.3.1.3. South Korea
- 15.3.2. By Product
- 15.3.3. By Application
- 15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
- 15.4.1. By Product
- 15.4.2. By Application
- 15.4.3. By Distribution Channel
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
- 15.8.1. China Opioids Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 15.8.1.2.1. By Product
    - 15.8.1.2.2. By Application
    - 15.8.1.2.3. By Distribution Channel
- 15.8.2. Japan Opioids Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 15.8.2.2.1. By Product
    - 15.8.2.2.2. By Application
    - 15.8.2.2.3. By Distribution Channel
- 15.8.3. South Korea Opioids Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 15.8.3.2.1. By Product
    - 15.8.3.2.2. By Application
    - 15.8.3.2.3. By Distribution Channel

16. South Asia Opioids Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. India
  - 16.3.1.2. Indonesia
  - 16.3.1.3. Malaysia
  - 16.3.1.4. Thailand
  - 16.3.1.5. Rest of South Asia
- 16.3.2. By Product
- 16.3.3. By Application
- 16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By Application
- 16.4.4. By Distribution Channel
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
- 16.8.1. India Opioids Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.8.1.2.1. By Product
    - 16.8.1.2.2. By Application
    - 16.8.1.2.3. By Distribution Channel
- 16.8.2. Indonesia Opioids Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.8.2.2.1. By Product
    - 16.8.2.2.2. By Application
    - 16.8.2.2.3. By Distribution Channel
- 16.8.3. Malaysia Opioids Market Analysis
  - 16.8.3.1. Introduction
  - 16.8.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.8.3.2.1. By Product
    - 16.8.3.2.2. By Application
    - 16.8.3.2.3. By Distribution Channel
- 16.8.4. Thailand Opioids Market Analysis
  - 16.8.4.1. Introduction
  - 16.8.4.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.8.4.2.1. By Product
    - 16.8.4.2.2. By Application
    - 16.8.4.2.3. By Distribution Channel

17. Oceania Opioids Market 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. Australia
  - 17.3.1.2. New Zealand
- 17.3.2. By Product
- 17.3.3. By Application
- 17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Application
- 17.4.4. By Distribution Channel
17.5. Key Market Participants - Intensity Mapping
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
- 17.8.1. Australia Opioids Market Analysis
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 17.8.1.2.1. By Product
    - 17.8.1.2.2. By Application
    - 17.8.1.2.3. By Distribution Channel
- 17.8.2. New Zealand Opioids Market Analysis
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 17.8.2.2.1. By Product
    - 17.8.2.2.2. By Application
    - 17.8.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Opioids Market Analysis 2019-2023 and Forecast 2024-2033

18.1. Introduction
18.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
- 18.3.1. By Country
  - 18.3.1.1. GCC Countries
  - 18.3.1.2. Turkey
  - 18.3.1.3. South Africa
  - 18.3.1.4. North Africa
  - 18.3.1.5. Rest of Middle East and Africa
- 18.3.2. By Product
- 18.3.3. By Application
- 18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
- 18.4.1. By Product
- 18.4.2. By Application
- 18.4.3. By Distribution Channel
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
- 18.8.1. GCC Countries Opioids Market Analysis
  - 18.8.1.1. Introduction
  - 18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 18.8.1.2.1. By Product
    - 18.8.1.2.2. By Application
    - 18.8.1.2.3. By Distribution Channel
- 18.8.2. Turkey Opioids Market Analysis
  - 18.8.2.1. Introduction
  - 18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 18.8.2.2.1. By Product
    - 18.8.2.2.2. By Application
    - 18.8.2.2.3. By Distribution Channel
- 18.8.3. South Africa Opioids Market Analysis
  - 18.8.3.1. Introduction
  - 18.8.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 18.8.3.2.1. By Product
    - 18.8.3.2.2. By Application
    - 18.8.3.2.3. By Distribution Channel
- 18.8.4. North Africa Opioids Market Analysis
  - 18.8.4.1. Introduction
  - 18.8.4.2. Market Analysis and Forecast, by Market Taxonomy
    - 18.8.4.2.1. By Product
    - 18.8.4.2.2. By Application
    - 18.8.4.2.3. By Distribution Channel

19. Market Structure Analysis

19.1. Market Analysis, by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis

20. Competition Analysis

20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
- 20.3.1. Pfizer, Inc.
  - 20.3.1.1. Overview
  - 20.3.1.2. Product Portfolio
  - 20.3.1.3. Sales Footprint
  - 20.3.1.4. Key Financials
  - 20.3.1.5. SWOT Analysis
  - 20.3.1.6. Strategy Overview
    - 20.3.1.6.1. Marketing Strategy
    - 20.3.1.6.2. Product Strategy
    - 20.3.1.6.3. Channel Strategy
- 20.3.2. Boehringer Ingelheim International GmbH
  - 20.3.2.1. Overview
  - 20.3.2.2. Product Portfolio
  - 20.3.2.3. Sales Footprint
  - 20.3.2.4. Key Financials
  - 20.3.2.5. SWOT Analysis
  - 20.3.2.6. Strategy Overview
    - 20.3.2.6.1. Marketing Strategy
    - 20.3.2.6.2. Product Strategy
    - 20.3.2.6.3. Channel Strategy
- 20.3.3. Janssen Pharmaceuticals, Inc.
  - 20.3.3.1. Overview
  - 20.3.3.2. Product Portfolio
  - 20.3.3.3. Sales Footprint
  - 20.3.3.4. Key Financials
  - 20.3.3.5. SWOT Analysis
  - 20.3.3.6. Strategy Overview
    - 20.3.3.6.1. Marketing Strategy
    - 20.3.3.6.2. Product Strategy
    - 20.3.3.6.3. Channel Strategy
- 20.3.4. Sanofi SAIS
  - 20.3.4.1. Overview
  - 20.3.4.2. Product Portfolio
  - 20.3.4.3. Sales Footprint
  - 20.3.4.4. Key Financials
  - 20.3.4.5. SWOT Analysis
  - 20.3.4.6. Strategy Overview
    - 20.3.4.6.1. Marketing Strategy
    - 20.3.4.6.2. Product Strategy
    - 20.3.4.6.3. Channel Strategy
- 20.3.5. Sun Pharmaceutical Industries Ltd.
  - 20.3.5.1. Overview
  - 20.3.5.2. Product Portfolio
  - 20.3.5.3. Sales Footprint
  - 20.3.5.4. Key Financials
  - 20.3.5.5. SWOT Analysis
  - 20.3.5.6. Strategy Overview
    - 20.3.5.6.1. Marketing Strategy
    - 20.3.5.6.2. Product Strategy
    - 20.3.5.6.3. Channel Strategy
- 20.3.6. Actavis Plc. [Teva Pharmaceutical Industries Ltd.]
  - 20.3.6.1. Overview
  - 20.3.6.2. Product Portfolio
  - 20.3.6.3. Sales Footprint
  - 20.3.6.4. Key Financials
  - 20.3.6.5. SWOT Analysis
  - 20.3.6.6. Strategy Overview
    - 20.3.6.6.1. Marketing Strategy
    - 20.3.6.6.2. Product Strategy
    - 20.3.6.6.3. Channel Strategy
- 20.3.7. Mallinckrodt Pharmaceuticals
  - 20.3.7.1. Overview
  - 20.3.7.2. Product Portfolio
  - 20.3.7.3. Sales Footprint
  - 20.3.7.4. Key Financials
  - 20.3.7.5. SWOT Analysis
  - 20.3.7.6. Strategy Overview
    - 20.3.7.6.1. Marketing Strategy
    - 20.3.7.6.2. Product Strategy
    - 20.3.7.6.3. Channel Strategy
- 20.3.8. Endo Pharmaceuticals Inc. [Endo International plc]
  - 20.3.8.1. Overview
  - 20.3.8.2. Product Portfolio
  - 20.3.8.3. Sales Footprint
  - 20.3.8.4. Key Financials
  - 20.3.8.5. SWOT Analysis
  - 20.3.8.6. Strategy Overview
    - 20.3.8.6.1. Marketing Strategy
    - 20.3.8.6.2. Product Strategy
    - 20.3.8.6.3. Channel Strategy
- 20.3.9. Purdue Pharma L.P.
  - 20.3.9.1. Overview
  - 20.3.9.2. Product Portfolio
  - 20.3.9.3. Sales Footprint
  - 20.3.9.4. Key Financials
  - 20.3.9.5. SWOT Analysis
  - 20.3.9.6. Strategy Overview
    - 20.3.9.6.1. Marketing Strategy
    - 20.3.9.6.2. Product Strategy
    - 20.3.9.6.3. Channel Strategy
- 20.3.10. Assertio Therapeutics, Inc. (Assertio Holdings, Inc.)
  - 20.3.10.1. Overview
  - 20.3.10.2. Product Portfolio
  - 20.3.10.3. Sales Footprint
  - 20.3.10.4. Key Financials
  - 20.3.10.5. SWOT Analysis
  - 20.3.10.6. Strategy Overview
    - 20.3.10.6.1. Marketing Strategy
    - 20.3.10.6.2. Product Strategy
    - 20.3.10.6.3. Channel Strategy